-
Featured Authors
-
Archives
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: massachusetts
Five Countries, One Goal: Collaboration with Global Impact in the Life Sciences Industry
During the 2013 BIO International Convention, the Massachusetts Life Sciences Center (MLSC) and regions from four other countries launched the new International Collaborative Industry Program (ICIP). The MLSC will partner with Victoria, Australia; the Wallonia region of Belgium; Quebec, Canada; and Alsace in France to award funding to projects promoting innovative and collaborative research and development (R&D) between companies in Massachusetts and in the partnering regions. The program’s goal is to develop long-term collaborations to advance late-stage R&D projects in biotechnology, pharmaceuticals, medical Read More >
New Report Shows Strength of Massachusetts’ Biotech Industry
If you read this blog, there’s a good chance you already know that Massachusetts is one of the biggest biotech hubs in the world. The Commonwealth’s successes in biotech economic development can be attributed to a number of things. Perhaps foremost, its world-class universities, such as MIT and Harvard, continue to churn out the innovation that keeps venture groups interested. Meanwhile, established biotechs and Big Pharma continue to focus more and more R&D work in Read More >
Massachusetts Governor and Lawmakers Improve Patient Access
Earlier this week Massachusetts Governor Deval Patrick signed the 2013 budget. Within that budget are two provisions that will ultimately benefit healthcare consumers within the Commonwealth. The first provision was a partial repeal of the Massachusetts gift ban law enacted two years ago. In the words of Governor Patrick, “This narrow change will afford healthcare providers some flexibility to be educated on new clinically relevant products and allow them to stay informed on advancements in Read More >
Senator John Kerry and the 2012 BIO International Convention
One of our scheduled keynote speakers at the 2012 BIO International Convention in Boston was Senator John Kerry of Massachusetts. Unfortunately the Senator was unable to join us as planned when his duties kept him in Washington, DC for votes on important legislation. Senator Kerry has been a strong supporter of biomedical innovation. During the health care reform debate, Senator Kerry strongly supported and fought for a 12-year data exclusivity period for innovative biomedicines and Read More >
2012 BIO International Convention: Exploring Massachusetts
By Bob Coughlin, President & CEO, MassBio Of course the 2012 BIO International Convention will be a great chance to connect, partner, network and learn. And convention-goers will have the chance to check out Boston’s Innovation District, which surrounds the Convention Center. But why not take some time while you’re in the Boston area to explore the biotech clusters outside metro Boston? There’s something for everyone here in Massachusetts! Head North of the City… The Read More >
